Vioxx

Pharmaceutical

Merck & Co. said Friday it will pay $4.85 billion to end thousands of lawsuits over its painkiller Vioxx in what is believed to be the largest drug settlement ever.



Pharmaceutical

Merck & Co., Inc. has agreed to pay $4.85 billion to resolve Vioxx related claims in which a claimant has suffered a heart attack, sudden cardiac death, or stroke.



Pharmaceutical

Merck & Co. said Friday it will pay $4.85 billion to end thousands of lawsuits over its painkiller Vioxx in what is believed to be the largest drug settlement ever.



Pharmaceutical

Company officials estimated the deal, if accepted, would end 45,000 to 50,000 personal injury lawsuits involving U.S. Vioxx users who suffered a heart attack or ischemic stroke, the type in which blood flow to the brain is blocked.



Pharmaceutical

Plaintiffs' lawyers this morning announced that Merck & Co. has agreed to pay $4.85 billion to settle the majority of claims over injuries linked to its Vioxx painkiller.



Pharmaceutical

After more than five years of hard-fought and difficult litigation, Merck has agreed to pay $4.85 billion, the largest pharmaceutical settlement in history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack (including sudden cardiac death) or a stroke.




Pharmaceutical

The maker of the painkiller Vioxx has agreed to pay more than $4.8 billion to settle thousands of lawsuits in one of the largest civil cases ever.



Pharmaceutical

Merck & Co. announced Friday that it will pay $4.85 billion to settle as claims by as many as 47,000 groups of plaintiffs over injuries linked to its blockbuster Vioxx painkiller.



Pharmaceutical

Montgomery law firm Beasley, Allen is on the winning side of a $4.85 billion settlement for users of the painkiller Vioxx who claim they were harmed by the drug.



Pharmaceutical

Wanting to move on from the legacy of its deadly painkiller, the maker of Vioxx, Merck & Co. this morning signed an agreement to pay $4.85 billion to settle the outstanding individual product liability claims against the drug.